Duodenal graft complications are poorly reported complications of pancreas transplantation that can result in graft loss. Excluding patients with early graft failure, after a median follow-up period of 126 months (range ) duodenectomy was required in 14 of 312 pancreas transplants (4.5%). All patients were insulin-independent at the time of diagnosis. Reasons for duodenectomy included delayed duodenal graft perforation (n = 10, 71.5%) and refractory duodenal graft bleeding (n = 4, 28.5%). In patients with duodenal graft bleeding, a total duodenectomy was performed. In patients with duodenal graft perforation, preservation of a duodenal segment was possible in five patients but completion duodenectomy was necessary in one patient. After total duodenectomy, immediate enteric duct drainage was feasible in seven patients. In two patients, a pancreaticocutaneous fistula was created that was subsequently converted to enteric drainage in one patient. In the other patient, enteric fistulization occurred as a consequence of silent pressure perforation of the draining catheter on the ascending colon. After a mean follow-up period of 52 months , all patients were alive, well, and insulin-independent. An aggressive and timely surgical approach may permit graft rescue in patients with severe duodenal graft complications occurring after pancreas transplantation. Generalization of these results remains to be established.
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clinical decision-making, clinical research/practice, complication: surgical/technical, diagnostic techniques and imaging: computed tomography, pancreas/simultaneous pancreas-kidney transplantation, surgical technique as a result of preservation injury or surgical misadventure, 4 or have a delayed presentation, sometimes as a consequence of viral infections or missed rejection. 5 In some patients, the causes of DGC cannot be accurately defined. 5 DGC are poorly discussed and described in the literature, but they are an important clinical problem, as they can lead to graft loss. 6, 7 Persistent DGC may have life-threatening consequences.
Thus, when all conservative therapies fail, the safest option is graft pancreatectomy. 6 In 2005, we described a modified technique for PTx that uses portal-enteric drainage of pancreas grafts: the transplantation procedure is performed via a transperitoneal approach, but the pancreas graft is eventually placed into a fully retroperitoneal position. 8 Subsequently, other authors have adopted our technique using a systemic venous drainage in the inferior vena cava. 9, 10 One of the potential advantages of retroperitoneal graft location behind the right colon is that septic complications of PTx may remain localized as peripancreatic fluid collections, instead of causing a peritonitis.
We herein present incidence, treatment, and outcome of DGC requiring duodenectomy occurring in a series of 336 consecutive retroperitoneal PTxs.
| MATERIALS AND METHODS
All grafts were procured 11 and preserved 12 as previously described.
Grafts were flushed and preserved in either a UW solution (n = 154)
or Celsior solution (n = 182). All pancreas grafts were placed in the retroperitoneal space behind the right colon. 8 Venous drainage was either created in the superior mesenteric vein (n = 170), as originally described, or in the inferior vena cava (n = 166).
Specifically regarding the concerns of the management of graft duodenum, at the back table, the second duodenal portion was trimmed to a length of 6 to 8 cm and duodenal stumps were stapled. Staple lines were reinforced with a running suture of 2/0 of polyglactin 910 and they were invaginated in a purse string suture of 0 of polyglactin 910. Before proceeding with arterial reconstruction, which was achieved using a Y-iliac donor graft, blood supply to the head of the pancreas/duodenum, as well as patency of collateral circulation between the superior mesenteric and splenic pedicles, was checked by injecting a small amount of preservation fluid into either the superior mesenteric artery or the splenic artery. The test was considered satisfactory if outflow was immediately obtained from the portal vein, the gastro-duodenal artery, and the superior mesenteric artery or the splenic artery, depending on the site of injection. For two recipients (0.6%), the test failed and the gastroduodenal artery was selectively revascularized.
In recipients, a Roux-en-Y jejunal limb was used and a duodenojejunostomy was performed side-by-side, with an outer layer of interrupted nonabsorbable sutures and an inner running layer of 3/0 polyglactin 910 sutures.
Regarding graft allocation, cytomegalovirus-(CMV-) negative patients received preferentially grafts from CMV-negative donors. SPK grafts were allocated to suitable recipients based on their blood group compatibility, without searching for a specific HLA matching. Solitary grafts were also allocated to recipients based on their blood group compatibility, and the best possible HLA matching was instead sought for the HLA-A and -B loci. [13] [14] [15] A CDC-negative T-cell crossmatch was required for all recipient categories. The final decision on graft acceptance was based on a comprehensive evaluation of donor characteristics, recipient needs, immunologic parameters, and duration of cold preservation time.
Immunosuppression consisted of a quadruple sequential regimen.
Induction included steroids boluses in all patients plus thymoglobulin (n = 108; 32.1%) or basiliximab (n = 228; 67.9%). Steroids were tapered to 5 mg per day, by the first post-PTx month. Maintenance therapy was based on low-dose steroids, calcineurin inhibitors (tacrolimus, n = 281; 83.6% or cyclosporine, n = 55; 16.4%), and mycophenolate mofetil. Ganciclovir was used in all recipients, but dosages and the length of administration were tailored based on donor-recipient matching. 8 Antithrombotic prophylaxis was used in every recipient according to the protocols described previously. 8 Recipients were seen at our center every month during the first year after PTx, every three months during the second year, and every six months thereafter, if not otherwise necessary.
Once a DGC was suspected, the diagnosis was confirmed, and anatomy of the lesion was defined by contrast-enhanced computed tomography (CT) and other imaging modalities, as required. Complete immunologic and virologic work-ups were also performed in every patient.
If the correct diagnosis was established within 72 hours from the onset of symptoms, patients were considered to have received an immediate diagnosis. If the initial diagnosis differed from the DGC, and the diagnostic delay exceeded 72 hours, patients were considered to have had a delayed diagnosis.
Patients with confirmed diagnosis of duodenal perforation (DGP) or refractory bleeding from the duodenal graft (DGB) were reoperated. The type of duodenal resection was based on the anatomy of DGC. In patients requiring a total duodenectomy, immediate duct drainage into the bowel 6 was pursued only if local and general conditions were permissive. In the other patients, the accessory pancreatic duct was ligated, and the main pancreatic duct was drained externally using a Bracci's urologic catheter of suitable calibre ( Figure 1 ). Fluid samples and swabs for culture were obtained from all patients. Large bore silastic drains were left close to the site of duodenal resection or reconstruction. In patients receiving external duct drainage, particular attention was paid to drain all sites, since pancreatic fistula was expected to occur, and the stagnation of leaking pancreatic juice had to be avoided.
Post-operative complications were classified using the ClavienDindo grading system. 16 In patients with more than one complication, the highest grade was considered, and complications ≥ grade 3
were considered severe. 17 Further, the comprehensive complication index (CCI) was calculated for each patient to summarize the burden of multiple complications occurring in a single patient. 18 Postoperative pancreatic fistula (POPF) was classified according to the definition of the International Study Group for Pancreatic Surgery (ISGPS).
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Pancreas graft loss was determined when the patient required exogenous insulin to remain euglycemic or when the patient died. P < .05 were considered to be significant. Twenty-four pancreas grafts (7.1%) were lost in the early postoperative period, because of vascular thrombosis (n = 12; 3.6%), humoral rejection (n = 6; 1.8%), and patient death (n = 6; 1.8%). Patient and graft survival curves have been reported in Figure 2 .
| RESULTS

Between
After a median follow-up period of 126 months (range for external duct drainage, and 326 (±39 minutes) for total graft duodenectomy.
All patients with DGB were treated with total graft duodenectomy and the duct drainage was reconstructed by means of a ductto-mucosa anastomosis on a Roux-en Y jejunal limb, as previously described. 6 In three patients both pancreatic ducts were drained into the gut, while in another patient the main pancreatic duct was drained and the accessory duct was ligated.
After DGP, partial graft duodenectomy was possible in five patients, but in one patient completion of duodenectomy was required because of bleeding from the duodenal graft. Total duodenectomy was immediately required in five recipients, but primary reconstruction was possible only in three. In the remaining two recipients, external duct drainage was preferred. In one of these patients, enteric drainage was accomplished 10 months later. In the other patient, enteric fistulization occurred as a consequence of pressure perforation, which was caused by the draining catheter on the ascending colon, 24 months after graft duodenectomy (Figure 3 ). At the longest follow-up of 120 months this patient remains well and insulin independent, without evidence of pseudocyst formation or dilation of the pancreatic duct.
Post-operative complications developed in one out of four patients after graft duodenectomy for DGB and in eight out of ten patients after graft duodenectomy for DGP. In the latter group, complications not only occurred more frequently, but more invasive treatments were also required since interventional radiology procedures were required in six patients and repeat surgery in three. Reoperation was required because of small bowel perforation caused by a volvolus, intrabdominal bleeding, and bleeding from residual donor duodenum following partial duodenectomy (Table 2) . DGP was also associated with relevant diagnostic difficulties, as reflected by a delay in diagnosis in six patients. Interestingly enough, all these six patients were not immediately referred to our center and were initially treated for graft pancreatitis (n = 4) or graft rejection As depicted in Table 3 , a delayed diagnosis was typically associated with DGP and entailed a worse, early outcome. Despite this, all patients with refractory bleeding required total duodenectomy by definition; they did better than recipients with DGP possibly because of a combination of timely diagnosis and lack of sepsis or peri-graft inflammation at the baseline. In this small series of DGC, all grafts were eventually rescued.
| DISCUSSION
DGC are treacherous and severe complications associated with PTx.
Delayed DGC may be difficult to diagnose in the absence of a high degree of suspicion 4, 5 and allograft pancreatectomy may become necessary. 20 Total and partial graft duodenectomy may be conveniently employed in suitable patients 6 to attempt graft rescue, but proper patient selection is mandatory.
Pancreas-preserving total duodenectomy, described in an animal model in 1922, 21 was first reported in man in 1995. 22 This procedure is performed to treat a variety of conditions, such as tumors diffusely involving the duodenal mucosa without transmural spread, 23 duodenal Crohn's disease, 24 multiple giant duodenal lipomas, 25 and blunt duodenal trauma. 26 In patients with intestinal amyloidosis, 27 as well as with cytomegalovirus duodenitis, 28 total duodenectomy is performed primarily to stop enteric bleeding refractory to other treatments.
In PTx recipients, total graft duodenectomy has been reported very rarely. 6, 29, 30 In these patients, if a Roux-en-Y loop is not employed, the immediate transit of intestinal contents through the fragile pancreatointestinal anastomosis should be probably avoided by creating a diverting stoma above the donor duodenum. 30 Alternative approaches to graft duodenectomy include pancreaticoduodenectomy, 31 duct occlusion, 32 wirsungostomy, [33] [34] [35] [36] [37] [38] and allograft pancreatectomy followed by islet cell isolation and reinfusion. 39 Considering the shortage of pancreas donors, we suggest that all strategies should be used to preserve graft function, without jeopardizing recipient safety. In this respect, we would like to underscore the role of wirsungostomy, a procedure that couples safety with efficacy when immediate duct drainage is not feasible or indicated. Inserting an external stent, of suitable calibre, having side holes (like a Bracci's catheter), into the main pancreatic duct and placing some drains around the pancreatic head creates a controlled pancreatico-cutaneous fistula. This type of fistula is expected to be well tolerated and to pursue a benign course. This strategy is already employed in emergency pancreaticoduodenectomy due to trauma, 33 as well as in elective pancreaticoduodenectomy in patients at high risk for POPF. [34] [35] [36] Wirsungostomy is also used in the setting of grade C POPF as an alternative treatment to completion pancreatectomy. 37, 38 Our experience shows that graft salvage may be possible despite serious DGC. This undertaking begins with accurate diagnosis and involves a complex procedure. In patients with DGB, hemorrhage is self-evident and the true challenge lies in identifying the source of bleeding. This is not immediately possible in all patients and often requires multiple attempts and the use of several imaging modalities. 6 Once the diagnosis has been established, considering that graft duodenectomy is curative, we suggest that patients are either operated or referred to centers with experience in this rare procedure.
In patients with DGP, the challenge begins at an earlier stage, when In most of our patients with DGP, the clinical picture was similar to an acute appendicitis (pain in the right flank/right iliac fossa, nausea, and vomiting). We could rule out this diagnosis because we systematically remove the appendix at the time of transplantation. 8 Even by excluding acute appendicitis, differential diagnosis still included several conditions such as acute graft pancreatitis, pancreatic rejection, right-sided ovarian disease, and perforation of native intestines. On practical grounds, in the presence of the above-mentioned symptoms and signs, we strongly suggest that patients should receive a high-quality contrast-enhanced CT-scan. The CT-scan must be interpreted by radiologists familiar with transplant anatomy and aware of the unique spectrum of post-transplant complications. [41] [42] [43] Once the diagnosis of DGP has been established, we suggest that graft rescue should still be considered. In patients in whom the diagnosis has been delayed and there is evidence of sepsis or severe inflammation, immediate reconstruction would not be feasible or prudent. In these patients, a pancreatico-cutaneous fistula might be created, and reconstruction could be reconsidered under elective conditions.
In our series pancreas graft salvage was possible even in patients with DGP, possibly because of the limited peritoneal contamination associated with the retroperitoneal position of the pancreas graft. concerns. This conclusion is supported by the lower rate of graft rescue (approximately 30%) reported when the pancreas is placed intraperitoneally. 44 We have not been able to identify the cause of DGC in any of our patients. If lack of an identifiable aetiology for DGC is clearly a negative issue, it is still worth noting that all pancreas grafts were rescued by partial or total duodenectomy. Probably, in patients undergoing successful partial graft duodenectomy, DGC were caused by local factors, such as poor blood supply to the distal portion of the duodenal stump, while in patients requiring total duodenectomy systemic factors were involved. Since underlying rejection is among the possible causes of DGC, 5 it is worth noting that no patient in this small series developed graft rejection after graft rescue. Spetzler and co-workers, in a series of 12 patients with DGP, were able to identify signs of rejection in one patient but missed the causative agent in all the remaining patients. 44 Finally, we have not confirmed a higher incidence of DGC in recipients of solitary grafts, as previously reported, 43 although nearly 40% of our procedures were PTA or PAK. In the entire series of PTx, as expected, insulin-independence in recipients of solitary grafts was lower than in recipients of SPK. However, 15 years after PTx, 97.6% of the recipients of solitary grafts were still alive (vs 95.5% in SPK) and 73.8%
were also insulin-independent at this point of time (vs 86.2% in SPK).
In conclusion, our experience shows the feasibility of pancreas graft rescue in patients with DGC, including DGP. Generalization of these results remains to be established, but PTx surgeons should be aware of this possibility and retain all possible rescuing options in their cultural background.
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